查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1475189

全球電子處方市場研究報告 - 2024 年至 2032 年行業分析、規模、佔有率、成長、趨勢和預測

Global ePrescribing Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 233 Pages | 商品交期: 最快1-2個工作天內

價格

全球電子處方市場需求預計將從 2023 年的 30.7 億美元增至 2032 年近 159.5 億美元，2024-2032 年研究期間複合年成長率為 20.09%。

電子處方是電子處方的縮寫，是一種數位醫療技術，使醫療保健提供者能夠直接從其電子健康記錄 (EHR) 系統或電子處方軟體產生處方並將其傳輸到藥房。這個過程消除了對紙本處方的需求，減少了錯誤，提高了效率，並增強了病人的安全。它允許醫療保健提供者訪問患者用藥史、篩選藥物相互作用並將處方安全地發送到藥房，從而簡化藥物管理流程。此外，它還能促進醫療保健提供者之間更好的護理協調，並促進患者堅持用藥，從而改善醫療保健結果和藥物管理效率。

市場動態

醫療保健系統的數位化和電子健康記錄 (EHR) 的採用推動了對電子處方解決方案的需求。醫療保健專業人員越來越認知到電子處方的好處，例如提高用藥安全性、提高效率和減少用藥錯誤。此外，促進電子處方系統改善病患照護、降低醫療成本和打擊處方藥濫用的政府措施和法規也推動了市場的成長。此外，將電子處方解決方案與藥房系統、電子病歷和臨床決策支援工具整合，可擴展其功能和可用性，從而推動醫療保健提供者的採用。此外，COVID-19 大流行加速了遠距醫療和遠距醫療服務的採用，為供應商提供整合遠距醫療解決方案創造了機會。行動應用程式、電子事先授權功能和互通性標準等技術進步有助於市場成長。然而，互通性問題和對資料安全的擔憂可能會挑戰未來幾年的市場成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球電子處方市場的每個細分市場進行了包容性評估。電子處方產業的成長和趨勢為本研究提供了整體方法。

市場區隔

電子處方市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人口統計數據以及即將到來的機會。

按產品分類

  • 解決方案（整合解決方案、獨立解決方案）
  • 服務（支援、實施、培訓、網路）

按交付方式

  • 網路為基礎/雲端
  • 本地部署

按物質分類

  • 管制物質
  • 非管制物質

按用途

  • 手持式
  • 基於電腦的設備

按專業

  • 腫瘤學
  • 運動藥物
  • 神經病學
  • 心臟病學
  • 其他

按最終用途

  • 醫院
  • 辦公室醫生
  • 藥局
  • 其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲電子處方市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。電子處方市場的主要參與者包括 Allscripts Healthcare, LLC、Athenahealth、Change Healthcare、DrFirst、Epic Systems Corporation、McKesson Corporation、Networking Technology, Inc.、NXGN Management, LLC、Practice Fusion, Inc.、Surescripts。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章：前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法論
    • 市場研究過程
    • 市場研究方法論

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：處方 - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業動態
  • 波特五力分析
  • 市場吸引力分析
    • 按產品分類的市場吸引力分析
    • 按交付模式分類的市場吸引力分析
    • 按物質分類的市場吸引力分析
    • 按用途分類的市場吸引力分析
    • 專業市場吸引力分析
    • 按最終用途分類的市場吸引力分析
    • 市場吸引力分析：按地區

第 4 章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章：全球處方藥市場分析：按產品

  • 概述（按產品）
  • 歷史和預測數據
  • 按產品分析
  • 解決方案（整合解決方案、獨立解決方案）
  • 服務（支援、實施、培訓、網路）

第 6 章：全球處方藥市場分析：依交付模式分類

  • 按交付模式概述
  • 歷史和預測數據
  • 按交付模式分析
  • 網路為基礎/雲端
  • 本地部署

第 7 章：全球處方藥市場分析：依物質分類

  • 物質概述
  • 歷史和預測數據
  • 按物質分析
  • 管制物質
  • 非管制物質

第 8 章：全球處方藥市場分析：依用途

  • 按用途概述
  • 歷史和預測數據
  • 按用途分析
  • 手持式
  • 基於電腦的設備

第 9 章：全球處方藥市場分析：按專業

  • 按專業概述
  • 歷史和預測數據
  • 按專業分析
  • 腫瘤學
  • 運動藥物
  • 神經病學
  • 心臟病學
  • 其他

第 10 章：全球處方藥市場分析：依最終用途分類

  • 按最終用途分類的概述
  • 歷史和預測數據
  • 按最終用途分析
  • 醫院
  • 辦公室醫生
  • 藥局
  • 其他

第 11 章：全球處方藥市場分析：依地理位置

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區按國家銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲按國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 12 章：處方公司的競爭格局

  • E規定市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 13 章：公司簡介

  • 頂級公司市佔率分析
  • 市場集中度
  • Allscripts Healthcare LLC
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Athenahealth
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Change Healthcare
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • DrFirst
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Epic Systems Corporation
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • McKesson Corporation
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Networking Technology Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • NXGN Management LLC
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Practice Fusion Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Surescripts.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展

註 - 在公司概況中，財務詳細資料和最新進展視情況而定，或對私人公司而言可能不包括在內

Product Code: VMR112114362

The global demand for ePrescribing Market is presumed to reach the market size of nearly USD 15.95 Billion by 2032 from USD 3.07 Billion in 2023 with a CAGR of 20.09% under the study period 2024 - 2032.

ePrescribing, short for electronic prescribing, is a digital healthcare technology enabling healthcare providers to generate and transmit prescriptions to pharmacies directly from their electronic health record (EHR) systems or electronic prescribing software. This process eliminates the need for paper-based prescriptions, reducing errors, improving efficiency, and enhancing patient safety. It allows healthcare providers to access patient medication histories, screen for drug interactions, and send prescriptions securely to pharmacies, streamlining the medication management process. Additionally, it promotes better coordination of care among healthcare providers and facilitates medication adherence by patients, leading to improved healthcare outcomes and medication management efficiency.

MARKET DYNAMICS

The digitization of healthcare systems and adopting electronic health records (EHRs) drive the demand for electronic prescribing solutions. Healthcare professionals increasingly acknowledge the benefits of ePrescribing, such as improved medication safety, enhanced efficiency, and reduced medication errors. Additionally, government initiatives and regulations promoting ePrescribing systems to improve patient care, reduce healthcare costs, and combat prescription drug abuse fuel market growth. Moreover, integrating ePrescribing solutions with pharmacy systems, electronic medical records, and clinical decision support tools expands their functionality and usability, driving adoption among healthcare providers. Furthermore, the COVID-19 pandemic has hastened the adoption of telehealth and remote healthcare services, creating opportunities for vendors to offer integrated telemedicine solutions. Technological advancements such as mobile applications, electronic prior authorization capabilities, and interoperability standards contribute to market growth. However, interoperability issues and concerns about data security may challenge the market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of eprescribing. The growth and trends of eprescribing industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the eprescribing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Solutions (Integrated Solutions, Standalone Solutions)
  • Services (Support, Implementation, Training, Network)

By Delivery Mode

  • Web/Cloud-Based
  • On-Premises

By Substances

  • Controlled Substances
  • Non-Controlled Substances

By Usage

  • Handheld
  • Computer-Based Devices

By Specialties

  • Oncology
  • Sports Medicine
  • Neurology
  • Cardiology
  • Other

By End-Use

  • Hospital
  • Office-Based Physicians
  • Pharmacy
  • Other

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the ePrescribing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the ePrescribing market include Allscripts Healthcare, LLC, Athenahealth, Change Healthcare, DrFirst, Epic Systems Corporation, McKesson Corporation, Networking Technology, Inc., NXGN Management, LLC, Practice Fusion, Inc., Surescripts. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. EPRESCRIBING - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Delivery Mode
    • 3.7.3 Market Attractiveness Analysis By Substances
    • 3.7.4 Market Attractiveness Analysis By Usage
    • 3.7.5 Market Attractiveness Analysis By Specialties
    • 3.7.6 Market Attractiveness Analysis By End-use
    • 3.7.7 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL EPRESCRIBING MARKET ANALYSIS BY PRODUCT

  • 5.1. Overview By Product
  • 5.2. Historical and Forecast Data
  • 5.3. Analysis By Product
  • 5.4. Solutions (Integrated Solutions, Standalone Solutions) Historic and Forecast Sales By Regions
  • 5.5. Services (Support, Implementation, Training, Network) Historic and Forecast Sales By Regions

6. GLOBAL EPRESCRIBING MARKET ANALYSIS BY DELIVERY MODE

  • 6.1. Overview By Delivery Mode
  • 6.2. Historical and Forecast Data
  • 6.3. Analysis By Delivery Mode
  • 6.4. Web/Cloud-Based Historic and Forecast Sales By Regions
  • 6.5. On-Premises Historic and Forecast Sales By Regions

7. GLOBAL EPRESCRIBING MARKET ANALYSIS BY SUBSTANCES

  • 7.1. Overview By Substances
  • 7.2. Historical and Forecast Data
  • 7.3. Analysis By Substances
  • 7.4. Controlled Substances Historic and Forecast Sales By Regions
  • 7.5. Non-Controlled Substances Historic and Forecast Sales By Regions

8. GLOBAL EPRESCRIBING MARKET ANALYSIS BY USAGE

  • 8.1. Overview By Usage
  • 8.2. Historical and Forecast Data
  • 8.3. Analysis By Usage
  • 8.4. Handheld Historic and Forecast Sales By Regions
  • 8.5. Computer-Based Devices Historic and Forecast Sales By Regions

9. GLOBAL EPRESCRIBING MARKET ANALYSIS BY SPECIALTIES

  • 9.1. Overview By Specialties
  • 9.2. Historical and Forecast Data
  • 9.3. Analysis By Specialties
  • 9.4. Oncology Historic and Forecast Sales By Regions
  • 9.5. Sports Medicine Historic and Forecast Sales By Regions
  • 9.6. Neurology Historic and Forecast Sales By Regions
  • 9.7. Cardiology Historic and Forecast Sales By Regions
  • 9.8. Other Historic and Forecast Sales By Regions

10. GLOBAL EPRESCRIBING MARKET ANALYSIS BY END-USE

  • 10.1. Overview By End-use
  • 10.2. Historical and Forecast Data
  • 10.3. Analysis By End-use
  • 10.4. Hospital Historic and Forecast Sales By Regions
  • 10.5. Office-Based Physicians Historic and Forecast Sales By Regions
  • 10.6. Pharmacy Historic and Forecast Sales By Regions
  • 10.7. Other Historic and Forecast Sales By Regions

11. GLOBAL EPRESCRIBING MARKET ANALYSIS BY GEOGRAPHY

  • 11.1. Regional Outlook
  • 11.2. Introduction
  • 11.3. North America Sales Analysis
    • 11.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 11.3.2 North America By Segment Sales Analysis
    • 11.3.3 North America By Country Sales Analysis
    • 11.3.4 United States Sales Analysis
    • 11.3.5 Canada Sales Analysis
    • 11.3.6 Mexico Sales Analysis
  • 11.4. Europe Sales Analysis
    • 11.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 11.4.2 Europe By Segment Sales Analysis
    • 11.4.3 Europe By Country Sales Analysis
    • 11.4.4 United Kingdom Sales Analysis
    • 11.4.5 France Sales Analysis
    • 11.4.6 Germany Sales Analysis
    • 11.4.7 Italy Sales Analysis
    • 11.4.8 Russia Sales Analysis
    • 11.4.9 Rest Of Europe Sales Analysis
  • 11.5. Asia Pacific Sales Analysis
    • 11.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 11.5.2 Asia Pacific By Segment Sales Analysis
    • 11.5.3 Asia Pacific By Country Sales Analysis
    • 11.5.4 China Sales Analysis
    • 11.5.5 India Sales Analysis
    • 11.5.6 Japan Sales Analysis
    • 11.5.7 South Korea Sales Analysis
    • 11.5.8 Australia Sales Analysis
    • 11.5.9 South East Asia Sales Analysis
    • 11.5.10 Rest Of Asia Pacific Sales Analysis
  • 11.6. Latin America Sales Analysis
    • 11.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 11.6.2 Latin America By Segment Sales Analysis
    • 11.6.3 Latin America By Country Sales Analysis
    • 11.6.4 Brazil Sales Analysis
    • 11.6.5 Argentina Sales Analysis
    • 11.6.6 Peru Sales Analysis
    • 11.6.7 Chile Sales Analysis
    • 11.6.8 Rest of Latin America Sales Analysis
  • 11.7. Middle East & Africa Sales Analysis
    • 11.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 11.7.2 Middle East & Africa By Segment Sales Analysis
    • 11.7.3 Middle East & Africa By Country Sales Analysis
    • 11.7.4 Saudi Arabia Sales Analysis
    • 11.7.5 UAE Sales Analysis
    • 11.7.6 Israel Sales Analysis
    • 11.7.7 South Africa Sales Analysis
    • 11.7.8 Rest Of Middle East And Africa Sales Analysis

12. COMPETITIVE LANDSCAPE OF THE EPRESCRIBING COMPANIES

  • 12.1. EPrescribing Market Competition
  • 12.2. Partnership/Collaboration/Agreement
  • 12.3. Merger And Acquisitions
  • 12.4. New Product Launch
  • 12.5. Other Developments

13. COMPANY PROFILES OF EPRESCRIBING INDUSTRY

  • 13.1. Top Companies Market Share Analysis
  • 13.2. Market Concentration Rate
  • 13.3. Allscripts Healthcare LLC
    • 13.3.1 Company Overview
    • 13.3.2 Company Revenue
    • 13.3.3 Products
    • 13.3.4 Recent Developments
  • 13.4. Athenahealth
    • 13.4.1 Company Overview
    • 13.4.2 Company Revenue
    • 13.4.3 Products
    • 13.4.4 Recent Developments
  • 13.5. Change Healthcare
    • 13.5.1 Company Overview
    • 13.5.2 Company Revenue
    • 13.5.3 Products
    • 13.5.4 Recent Developments
  • 13.6. DrFirst
    • 13.6.1 Company Overview
    • 13.6.2 Company Revenue
    • 13.6.3 Products
    • 13.6.4 Recent Developments
  • 13.7. Epic Systems Corporation
    • 13.7.1 Company Overview
    • 13.7.2 Company Revenue
    • 13.7.3 Products
    • 13.7.4 Recent Developments
  • 13.8. McKesson Corporation
    • 13.8.1 Company Overview
    • 13.8.2 Company Revenue
    • 13.8.3 Products
    • 13.8.4 Recent Developments
  • 13.9. Networking Technology Inc.
    • 13.9.1 Company Overview
    • 13.9.2 Company Revenue
    • 13.9.3 Products
    • 13.9.4 Recent Developments
  • 13.10. NXGN Management LLC
    • 13.10.1 Company Overview
    • 13.10.2 Company Revenue
    • 13.10.3 Products
    • 13.10.4 Recent Developments
  • 13.11. Practice Fusion Inc.
    • 13.11.1 Company Overview
    • 13.11.2 Company Revenue
    • 13.11.3 Products
    • 13.11.4 Recent Developments
  • 13.12. Surescripts.
    • 13.12.1 Company Overview
    • 13.12.2 Company Revenue
    • 13.12.3 Products
    • 13.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product (USD MN)
  • Solutions (Integrated Solutions, Standalone Solutions) Market Sales By Geography (USD MN)
  • Services (Support, Implementation, Training, Network) Market Sales By Geography (USD MN)
  • Analysis By Delivery Mode (USD MN)
  • Web/Cloud-Based Market Sales By Geography (USD MN)
  • On-Premises Market Sales By Geography (USD MN)
  • Analysis By Substances (USD MN)
  • Controlled Substances Market Sales By Geography (USD MN)
  • Non-Controlled Substances Market Sales By Geography (USD MN)
  • Analysis By Usage (USD MN)
  • Handheld Market Sales By Geography (USD MN)
  • Computer-Based Devices Market Sales By Geography (USD MN)
  • Analysis By Specialties (USD MN)
  • Oncology Market Sales By Geography (USD MN)
  • Sports Medicine Market Sales By Geography (USD MN)
  • Neurology Market Sales By Geography (USD MN)
  • Cardiology Market Sales By Geography (USD MN)
  • Other Market Sales By Geography (USD MN)
  • Analysis By End-use (USD MN)
  • Hospital Market Sales By Geography (USD MN)
  • Office-Based Physicians Market Sales By Geography (USD MN)
  • Pharmacy Market Sales By Geography (USD MN)
  • Other Market Sales By Geography (USD MN)
  • Global EPrescribing Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of EPrescribing Report
  • Market Research Process
  • Market Research Methodology
  • Global EPrescribing Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Delivery Mode
  • Market Attractiveness Analysis By Substances
  • Market Attractiveness Analysis By Usage
  • Market Attractiveness Analysis By Specialties
  • Market Attractiveness Analysis By End-use
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product (USD MN)
  • Solutions (Integrated Solutions, Standalone Solutions) Market Sales By Geography (USD MN)
  • Services (Support, Implementation, Training, Network) Market Sales By Geography (USD MN)
  • Global Market Analysis By Delivery Mode (USD MN)
  • Web/Cloud-Based Market Sales By Geography (USD MN)
  • On-Premises Market Sales By Geography (USD MN)
  • Global Market Analysis By Substances (USD MN)
  • Controlled Substances Market Sales By Geography (USD MN)
  • Non-Controlled Substances Market Sales By Geography (USD MN)
  • Global Market Analysis By Usage (USD MN)
  • Handheld Market Sales By Geography (USD MN)
  • Computer-Based Devices Market Sales By Geography (USD MN)
  • Global Market Analysis By Specialties (USD MN)
  • Oncology Market Sales By Geography (USD MN)
  • Sports Medicine Market Sales By Geography (USD MN)
  • Neurology Market Sales By Geography (USD MN)
  • Cardiology Market Sales By Geography (USD MN)
  • Other Market Sales By Geography (USD MN)
  • Global Market Analysis By End-use (USD MN)
  • Hospital Market Sales By Geography (USD MN)
  • Office-Based Physicians Market Sales By Geography (USD MN)
  • Pharmacy Market Sales By Geography (USD MN)
  • Other Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.